Modeling the cost effectiveness of malaria control interventions in the highlands of western Kenya

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Stuckey, Erin M ^a,b   Stevenson, Jennifer ^c,d,e   Galactionova, Katya ^a,b   Baidjoe, Amrish Y ^f   Bousema, Teun ^c,f   Odongo, Wycliffe ^d   Kariuki, Simon ^d   Drakeley, Chris ^c   Smith, Thomas A ^a,b   Cox, Jonathan ^c   Chitnis, Nakul ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d Centre for Global Health Research   (Kenya)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE;

ARTICLE; BED NET; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; DRUG COST; ETHNICITY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HOUSEHOLD; HUMAN; KENYA; MALARIA; MALARIA CONTROL; PRACTICE GUIDELINE; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SIMULATION; ZOOLOGY; PREVALENCE; STATISTICAL MODEL; THEORETICAL MODEL;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; KENYA; MALARIA; MODELS, STATISTICAL; MODELS, THEORETICAL; PREVALENCE;

EID: 84907830990     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107700     Document Type: Article

References (56)

1. Feachem RG, Phillips AA, Targett GA, Snow RW (2010) Call to action: priorities for malaria elimination. Lancet 376: 1517-1521.
2. WHO (2013) World Malaria Report 2012. Geneva: World Health Organization.
3. OpenMalaria (2010) OpenMalaria. Available: http://code.google.com/p/openmalaria/wiki/Start. Accessed 2013 Jul 2.
4. Stuckey EM, Stevenson J, Cooke M, Owaga C, Marube E, et al. (2012) Simulation of malaria epidemiology and control in the highlands of western Kenya. Malar J 11.
5. Mabaso ML, Craig M, Ross A, Smith T (2007) Environmental predictors of the seasonality of malaria transmission in Africa: The challenge. Am J Trop Med Hyg 76: 33-38.
6. Kristan M, Abeku TA, Beard J, Okia M, Rapuoda B, et al. (2008) Variations in entomological indices in relation to weather patterns and malaria incidence in East African highlands: implications for epidemic prevention and control. Malar J 7: 231.
7. Stevenson JC, Stresman GH, Gitonga CW, Gillig J, Owaga C, et al. (2013) Reliability of school surveys in estimating geographic variation in malaria transmission in the western Kenyan highlands. PLOS One 8: e77641.
8. Department of Malaria Control, Kenya National Bureau of Statistics, ICF Macro (2011) 2010 Kenya Malaria Indicator Survey. Nairobi, Kenya.
9. Stevenson J, St. Lauernt B, Lobo N, Cooke M, Kahindi S, et al. (2012 Sept) Novel vectors of malaria parasite in the western highlands of Kenya [letter]. Emerg Infect Dis [serial on the Internet].
10. Fillinger U, Ndenga B, Githeko A, Lindsay SW (2009) Integrated malaria vector control with microbial larvicides and insecticide-treated nets in western Kenya: A controlled trial. Bull World Health Organ 87: 655-665.
11. Kenya Division of Malaria Control (2006) National Guidelines for Diagnosis, Treatment and Prevention of Malaria in Kenya. In: Management DoMCC, editor.
12. Chuma J, Okungu V (2011) Viewing the Kenyan health system through an equity lens: implications for universal coverage. Int J Equity Health 10: 22.
13. Government of Kenya (2013) Comprehensive Public Expenditure Review 2013. Nairobi, Kenya: Government of Kenya, Ministry of Devolution and Planning.
14. Bousema T, Stevenson J, Baidjoe A, Stresman G, Griffin JT, et al. (2013) The impact of hotspot-targeted interventions on malaria transmission: study protocol for a cluster-randomized controlled trial. Trials 14: 36.
15. Smith T, Killeen GF, Maire N, Ross A, Molineaux L, et al. (2006) Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. Am J Trop Med Hyg 75: 1-10.
16. Chitnis N, Smith T, Steketee R (2008) A mathematical model for the dynamics of malaria in mosquitoes feeding on a heterogeneous host population. Journal of Biological Dynamics 2: 259-285.
17. Smith T, Maire N, Ross A, Penny M, Chitnis N, et al. (2008) Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology 135: 1507-1516.
18. Smith T, Ross A, Maire N, Chitnis N, Studer A, et al. (2012) Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine. PLOS medicine 9: e1001157.
19. Chitnis N, Hardy D, Smith T (2012) A Periodically-Forced Mathematical Model for the Seasonal Dynamics of Malaria in Mosquitoes. Bulletin of mathematical biology 74(5): 1098-1124.
20. Akazili J, Aikins M, Binka F (2007) Malaria treatment in Northern Ghana: What is the treatment cost per case to households? African Journal of Health Sciences 14: 70-79.
21. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, et al. (2010) The costeffectiveness of intermittent preventive treatment for malaria in infants in Sub- Saharan Africa. PLOS One 5: e10313.
22. WHO (2010) Guidelines for the Treatment of Malaria, Second Edition. Geneva.
23. Wiseman V, Kim M, Mutabingwa TK, Whitty CJ (2006) Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLOS Med 3: e373.
24. Drummond MF, Sculpher M, Torrance G, O'Brien B, Stoddart G (2005) Methods for the Economic Evaluation of Health Care Programmes 3 ed. Oxford, United Kingdom: Oxford University Press.
25. Tediosi F, Maire N, Smith T, Hutton G, Utzinger J, et al. (2006) An approach to model the costs and effects of case management of Plasmodium falciparum malaria in sub-saharan Africa. Am J Trop Med Hyg 75: 90-103.
26. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB (1996) Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 276: 1253-1258.
27. Galactionova K, Penny M, Tediosi F, de Savigny D, Smith T (2013) Impact of Health System Factors on Health Benefits and Cost-Effectiveness of a Malaria Vaccine; presented at The 9th World Congress on Health Economics: "Celebrating Health Economics", July 8, 2013; Sydney, Australia.
28. Kenya National Bureau of Statistics, ICF Macro (2010) Kenya Demographic and Health Survey 2008-09. Calverton, Maryland: KNBS and ICF Macro.
29. Watsierah CA, Jura WG, Oyugi H, Abong'o B, Ouma C (2010) Factors determining anti-malarial drug use in a peri-urban population from malaria holoendemic region of western Kenya. Malar J 9: 295.
30. Nyandigisi A, Memusi D, Mbithi A, Ang'wa N, Shieshia M, et al. (2011) Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya. PLOS One 6: e24781.
31. Goodman C, Coleman P, Mills A (2000) Economic analysis of malaria control in Sub-Saharan Africa. Global Forum for Health Research.
32. WHO (2011) CHOosing interventions that are cost-effective: country-specific unit costs. Geneva, Switzerland: World Health Organization.
33. World Bank (2013) Implicit Price Deflators for Gross Domestic Product.
34. Batwala V, Magnussen P, Hansen KS, Nuwaha F (2011) Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J 10: 372.
35. Malaria Vaccine Initiative (2012) Estimating the economic burden of malaria in Nigeria. Malaria Vaccine Initiative.
36. Kirigia JM, Snow RW, Fox-Rushby J, Mills A (1998) The cost of treating paediatric malaria admissions and the potential impact of insecticide-treated mosquito nets on hospital expenditure. Trop Med Int Health 3: 145-150.
37. Kolaczinski J, Hanson K (2006) Costing the distribution of insecticide-treated nets: A review of cost and cost-effectiveness studies to provide guidance on standardization of costing methodology. Malar J 5: 37.
38. Global Fund to fight AIDS, TB and Malaria (2013) Price and Quality Reporting Tool.
39. White MT, Conteh L, Cibulskis R, Ghani AC (2011) Costs and costeffectiveness of malaria control interventions-a systematic review. Malar J 10: 337.
40. Oanda (2013) Historical Exchange Rates. Available at: http://www.oanda.com/.
41. Murray CJ, Lopez AD (1996) The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 to 2020. Cambridge, MA, USA: Harvard University Press.
42. INDEPTH Network (2004) Model life tables for Sub-Saharan Africa. Aldershot, United Kingdom: INDEPTH Network.
43. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disabilityadjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990- 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223.
44. Brooker S, Okello G, Njagi K, Dubeck MM, Halliday KE, et al. (2010) Improving educational achievement and anaemia of school children: design of a cluster randomised trial of school-based malaria prevention and enhanced literacy instruction in Kenya. Trials 11: 93.
45. Halliday KE, Okello G, Turner EL, Njagi K, Mcharo C, et al. (2014) Impact of Intermittent Screening and Treatment for Malaria among School Children in Kenya: A Cluster Randomised Trial. PLOS Med 11: e1001594.
46. UNITAID (2013) Malaria Vector Control Commodities Landscape. Geneva: WHO.
47. RTI International (2013) Indoor Residual Spraying (IRS) 2 for Malaria Control. Task Order 1 - Final Report. Research Triangle Park, NC: RTI International.
48. WHO (2014) The Global Burden of Disease: 2012. Geneva: WHO.
49. WHO-CHOICE (2005) AFR E: Cost effectiveness results for Malaria. Geneva: WHO.
50. WHO-CHOICE (2005) AFR E: Cost effectiveness results for Tuberculosis. Geneva: WHO.
51. WHO-CHOICE (2005) AFR E: Cost effectiveness results for HIV/AIDS. Geneva: WHO.
52. Mikkelsen-Lopez I, Wyss K, de Savigny D (2011) An approach to addressing governance from a health system framework perspective. BMC Int Health Hum Rights 11: 13.
53. International Association for Impact Assessment (2006) Health Impact Assessment: International Best Practice Principles. Fargo, ND.
54. Management Sciences for Health (2011) International Drug Price Indicator Guide. Cambriage, MA: MSH.
55. Guyatt HL, Kinnear J, Burini M, Snow RW (2002) A comparative cost analysis of insecticide-treated nets and indoor residual spraying in highland Kenya. Health Policy Plan 17: 144-153.
56. Drake TL, Okello G, Njagi K, Halliday KE, Jukes M, et al. (2011) Cost analysis of school-based intermittent screening and treatment of malaria in Kenya. Malar J 10: 273.